Key facts
- It has raised $110.1M; the latest was PE Growth/Expansion ($110.1M) in Jan 2025.
- Notable investors include Kotak Alternate Assets Managers.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Neuberg Diagnostics
- ·The full record, as it builds
Funding rounds
No funding rounds for Neuberg Diagnostics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Neuberg Diagnostics
Provider of clinical laboratory testing services intended to serve across India, UAE and South Africa. The company offers services such as blood tests, ECG, digital X-rays, digital mammography, sonography, stress tests, spirometry and audiometry, thereby promoting prevention and early diagnosis of rare diseases using the most advanced technologies assisted by data science and AI tools.
- Sector
- Healthcare
- HQ
- Chennai, India
- Founded
- 1938
- Employees
- 2,000
- Website
- neubergdiagnostics.com/
- Ownership
- Privately Held (backing)
Neuberg Diagnostics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Neuberg Diagnostics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Neuberg Diagnostics in its N-PORT filings yet. We sweep new filings monthly.